Jade Hsu, President
Jade joined CBA in 2023 and has been actively involved in organizing CBA events. Currently, she serves as the Senior Business Development Manager at Biocytogen, a pre-clinical CRO specializing in gene editing, humanized animal/cell models, and disease models. With a background in the biotechnology and pharmaceutical sectors, Jade brings extensive experience in research and development from both the United States and Taiwan. Her expertise spans pre-clinical drug development and product development in sequencing-related fields. During her academic endeavors, she focused on drug repurposing for lung cancer therapeutics.
Huixun (Zoe) Du, Conference Chair
Huixun (Zoe) Du joined CBA in 2024 and is currently a postdoctoral fellow at the Buck Institute. She earned her PhD in the Biology of Aging from the University of Southern California, where she focused on immune dysfunction and its mechanistic links to aging. Outside of research, she enjoys sports and anime in her spare time.
Frank Zhou, Vice President
Mengning “Frank” Zhou, Ph.D., ChFC ®, has been a lifetime member of CBA since 2010. He has volunteered for CBA for several years in different capacities. Beginning in 2020, he has taken the role of Director of Operation. He also volunteers for US-China Green Energy Council and is a Vice President there. He is a full-time Financial Planner at MassMutual Northern California with a fiduciary obligation to his clients. He also has a part-time appointment in Stanford University School of Medicine where he helps to push back the frontiers of cancer research. Prior to these positions, he was a research scientist developing biochemical assays and nucleic acid testing (NAT) for infectious diseases, leading to a USPTO granted patent. He earned his Ph.D. in Biological Sciences from Carnegie Mellon University after he received his B.S. from Fudan University.
Kaiqing Zhang, Sponsorship Director
Shengqin Su, Operations Director
Shengqin Su has been a dedicated member of CBA since 2023. He is currently a Research Scientist at Stanford University. Previously, he worked in biomarker development at Hengrui Pharmaceuticals and early colorectal cancer detection at Singlera Genomics. He received his Ph.D. in Biomedical Science and an M.S. in Applied Statistics from UW-Madison, as well as an M.S. in Nanoengineering from UC San Diego.
Dan Zhang, Alliance Director
Dan is a dynamic business leader and Vice President at Q Bay Center, a Silicon Valley-based platform that connects innovation and entrepreneurship. With a background in journalism, Dan has extensive experience in media and communication, which she brings to her work in entrepreneurial eco-system building, event organization, and business development.
Jia Jun Chia, Proceedings Director
Jia Jun is currently a Senior Associate Scientist at Gilead Sciences working in the Virology department as a researcher on the Hepatitis B cure program. Prior to moving to the Bay Area, she was a graduate student at the University of Washington in Seattle, where she earned an MS in Bioengineering and investigated the role of vascular smooth muscle cells in the calcification of the brain vasculature. She also obtained a BS in Chemical and Biomolecular Engineering from Johns Hopkins University. She joined CBA in 2017 as a volunteer to help with videography, and served as the webmaster from 2019 to 2023. She was also CBA’s president in 2024. In her spare time, she enjoys reading, doing escape rooms and spending time with her family.
David Hsieh, Marketing Director
David is a biopharmaceutical researcher with more than 10 years of experience in drug discovery, spanning cancer research, virology, and cell and gene therapy. His primary focus is preclinical cancer research for small molecule therapeutics, informed by his study of targeted therapeutics in lung cancer in the Thoracic Oncology Laboratory at UCSF. He holds a B.A. in Molecular and Cell Biology from UC Berkeley and a M.S. in Biochemistry and Molecular Biology from UCLA.
Molly (Ting-Yu) Lin, Treasurer
Molly is a biochemist and cell biologist with over a decade of experience in protein function and cell signaling, focusing on cancer and metabolic diseases. Currently a scientist at Calico Life Sciences, Molly specializes in leveraging cutting-edge technologies and developing cellular models to explore the complex processes underlying aging and age-related diseases. Before joining the industry, Molly earned her Ph.D. in Cell & Developmental Biology from Weill Cornell Medicine, New York. Outside of work, she enjoys hiking, traveling, and discovering new cuisines.